The page is the record's research on the issuer — no analyst, no rating, no view. # RTW BIOTECH OPPORTUNITIES LTD (LSE Main Market: RTW) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is RTW BIOTECH OPPORTUNITIES LTD, listed on the LSE Main Market under ticker RTW, ISIN GG00BKTRRM22, LEI 549300Q7EXQQH6KF7Z84. Its security type is Fund (FUND), segment STMM, sector Closed End Investments [302040], jurisdiction Guernsey (GG). Its listing status is listed, not halted. ## The disclosure read The record holds 0 filings in the window 2025-11-06 to 2026-11-06, on 0 filing days. The median gap between filing days is not on the record. The latest filing date is not on the record, and so is the days from latest filing to record date (2026-11-06). The LSE Main Market peers have a median cadence gap of 4 days, a median of 29.0 filings, and a median latency of 3 days across 892 issuers. The sector peers, Closed End Investments [302040], have a median cadence gap of 5.5 days, a median of 0 filings, and a median latency of 4.5 days across 269 issuers. The issuer's latest filing type is not on the record. ## Auditor The auditor is not on the record, as the record was not searched for this security type (fund, receipt or debt security). The auditor location is not on the record. Auditor changes are not on the record, as the market's record carries no lifecycle type map for this register yet. ## Events and halts The listing, delisting, name change, domicile change and segment move lines are not on the record, as the market's record carries no lifecycle type map for this register yet. The halt flag shows listed, not halted. ## Orderability The elective professional client outcome is ACM-200, determinable. The eligible counterparty outcome is ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page; the count is 0. ## Open research The record holds 3 openly published research notes. Edison Investment Research published on 2023-11-01, on 2023-07-05 and on 2022-01-11. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed on the record. The live record began on 2026-09-11. The years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed. ## Sources 12 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/RTW (identity.isin) - https://api.gleif.org/api/v1/lei-records/549300Q7EXQQH6KF7Z84 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/RTW/rtw-biotech-opportunities-ltd/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/LSE/RTW (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.edisongroup.com/research/significant-acquisition-of-arix-bioscienceas-assets/32844/ (open research) - https://www.edisongroup.com/research/use-of-prometheus-biosciences-sale-proceeds/32480/ (open research) - https://www.edisongroup.com/research/one-stop-shop-for-biotech-lifecycle-investment/30382/ (open research) - https://mcp.uk-cm-kg.ai/record/LSE/RTW (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/LSE/RTW · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp